Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer |
| |
Authors: | Jianpei Li Jianhua Lin Yaoling Luo Miaohuan Kuang Yijun Liu |
| |
Institution: | Department of Clinical laboratory, State Key Laboratory of Oncology in South China/Cancer Center of Sun Yat-sen University, Guangzhou, Guangdong province, PR China.; Istituto dei tumori Fondazione Pascale, ITALY, |
| |
Abstract: | ObjectiveThe aim of this study was to identify biomarkers with prognostic value in the setting of surgically treated endometrial cancer.MethodsMedical data for 282 patients with surgically treated endometrial cancer were reviewed retrospectively. Preoperative concentrations of six serum biomarkers (CA125, CA15-3, C-reactive protein CRP], D-dimer D-D], platelet-to-lymphocyte ratio PLR], and neutrophil-to-lymphocyte ratio NLR]) were analysed to determine potential associations with clinicopathologic characteristics and to assess prognostic values separately via Kaplan-Meier method and multivariate Cox regression.ResultsIn univariate analyses, the 5-year overall survival (OS) rate was 86.5% for a maximum follow-up period of 75 months. High concentrations of CA125, CA15-3, CRP, D-D, PLR, and NLR each proved significantly predictive of poor survival (log-rank test, P<0.01). CRP and D-D were identified as independent prognosticators, using a Cox regression model. Study patients were then stratified (based on combined independent risk factors) into three tiers (P<0.001), marked by 5-year OS rates of 92.1%, 78.4%, and 33.3%.ConclusionsAll serum biomarkers assessed (CA125, CA15-3, CRP, D-D, PLR, and NLR) proved to be valid prognostic indices of surgically treated endometrial cancer. A novel prognostic grouping system, incorporating independent risk factors (CRP and D-D Concentrations), may have merit in assessing these patients preoperatively, providing a biologic basis for improved clinical staging. |
| |
Keywords: | |
|
|